148 related articles for article (PubMed ID: 11454425)
1. Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation.
Debiec-Rychter M; Lasota J; Sarlomo-Rikala M; Kordek R; Miettinen M
Cancer Genet Cytogenet; 2001 Jul; 128(1):24-30. PubMed ID: 11454425
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
3. Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors. Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor.
Yasuoka R; Sakakura C; Shimomura K; Fujita Y; Nakanishi M; Aragane H; Hagiwara A; Bamba M; Abe T; Yamagishi H
Dig Surg; 2003; 20(3):183-91. PubMed ID: 12759497
[TBL] [Abstract][Full Text] [Related]
4. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.
Lasota J; Jasinski M; Sarlomo-Rikala M; Miettinen M
Am J Pathol; 1999 Jan; 154(1):53-60. PubMed ID: 9916918
[TBL] [Abstract][Full Text] [Related]
5. KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin.
Lasota J; Kopczynski J; Sarlomo-Rikala M; Schneider-Stock R; Stachura T; Kordek R; Michal M; Boltze C; Roessner A; Stachura J; Miettinen M
Hum Pathol; 2003 Dec; 34(12):1306-12. PubMed ID: 14691917
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
[TBL] [Abstract][Full Text] [Related]
7. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
Miettinen M; Majidi M; Lasota J
Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
[TBL] [Abstract][Full Text] [Related]
8. C-kit gene mutation in human gastrointestinal stromal tumors.
Hou YY; Tan YS; Sun MH; Wei YK; Xu JF; Lu SH; A-Ke-Su SJ; Zhou YN; Gao F; Zheng AH; Zhang TM; Hou WZ; Wang J; Du X; Zhu XZ
World J Gastroenterol; 2004 May; 10(9):1310-4. PubMed ID: 15112348
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors.
Wardelmann E; Losen I; Hans V; Neidt I; Speidel N; Bierhoff E; Heinicke T; Pietsch T; Büttner R; Merkelbach-Bruse S
Int J Cancer; 2003 Oct; 106(6):887-95. PubMed ID: 12918066
[TBL] [Abstract][Full Text] [Related]
10. Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors.
Gunawan B; Bergmann F; Höer J; Langer C; Schumpelick V; Becker H; Füzesi L
Hum Pathol; 2002 Mar; 33(3):316-21. PubMed ID: 11979372
[TBL] [Abstract][Full Text] [Related]
11. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA
Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439
[TBL] [Abstract][Full Text] [Related]
12. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and c-Kit mutation in gastrointestinal stromal tumors.
Lee JH; Zhang X; Jung WY; Chae YS; Park JJ; Kim I
World J Gastroenterol; 2004 Dec; 10(23):3475-9. PubMed ID: 15526368
[TBL] [Abstract][Full Text] [Related]
14. KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs).
Tabone S; Théou N; Wozniak A; Saffroy R; Deville L; Julié C; Callard P; Lavergne-Slove A; Debiec-Rychter M; Lemoine A; Emile JF
Biochim Biophys Acta; 2005 Jun; 1741(1-2):165-72. PubMed ID: 15869870
[TBL] [Abstract][Full Text] [Related]
15. Complex genetic alterations in gastrointestinal stromal tumors with autonomic nerve differentiation.
Debiec-Rychter M; Pauwels P; Lasota J; Franke S; De Vos R; De Wever I; Hagemeijer A; Sciot R
Mod Pathol; 2002 Jul; 15(7):692-8. PubMed ID: 12118105
[TBL] [Abstract][Full Text] [Related]
16. Consistent DNA losses on the short arm of chromosome 1 in a series of malignant gastrointestinal stromal tumors.
Derré J; Lagacé R; Terrier P; Sastre X; Aurias A
Cancer Genet Cytogenet; 2001 May; 127(1):30-3. PubMed ID: 11408061
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors.
Singer S; Rubin BP; Lux ML; Chen CJ; Demetri GD; Fletcher CD; Fletcher JA
J Clin Oncol; 2002 Sep; 20(18):3898-905. PubMed ID: 12228211
[TBL] [Abstract][Full Text] [Related]
18. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases.
Lasota J; Wozniak A; Sarlomo-Rikala M; Rys J; Kordek R; Nassar A; Sobin LH; Miettinen M
Am J Pathol; 2000 Oct; 157(4):1091-5. PubMed ID: 11021812
[TBL] [Abstract][Full Text] [Related]
19. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature.
Ito T; Yamamura M; Hirai T; Ishikawa T; Kanda T; Nakai T; Ohkouchi M; Hashikura Y; Isozaki K; Hirota S
Int J Clin Exp Pathol; 2014; 7(11):8024-31. PubMed ID: 25550846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
